For immediate release

3 December 2009

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Oxford BioMedica Plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify): See note 13 re Barclays' disposal of the Barclays Global Investors business

Yes

3. Full name of person(s) subject to notification obligation:

Barclays PLC

4. Full name of shareholder(s) (if different from 3):

Barclays Stockbrokers Ltd

Gerrard Investment Management Ltd

5. Date of transaction (and date on which the threshold is crossed or reached if different):

1 December 2009

6. Date on which issuer notified:

2 December 2009

7. Threshold(s) that is/are crossed or reached:

7% to 5%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct 

Indirect

Direct

Indirect

GB0006648157

39,831,749

39,831,749

32,357,983

0

32,357,983

0.00%

5.98%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

Total (A+B)

Number of voting rights

Percentage of voting rights

32,357,983

5.98%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Barclays Stockbrokers Ltd

Gerrard Investment Management Ltd

Proxy Voting: 

10. Name of proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

On 1 December 2009, Barclays Group sold the

Barclays Global Investors business, including

Barclays Global Investors Ltd, Barclays Global

Investors (Deutschland) Ltd, Barclays Global

Investors N.A. and Barclays Global Fund Advisors

to BlackRock Inc. Accordingly, holdings of Barclays

Global Investors Ltd, Barclays Global Investors

(Deutschland) Ltd, Barclays Global Investors N.A.

and Barclays Global Fund Advisors are no longer

attributable to the Barclays Group/Barclays plc and

responsibility for making relevant shareholding

disclosures relating to holdings of Barclays Global

Investors Ltd, Barclays Global Investors

(Deutschland) Ltd, Barclays Global Investors N.A.

and Barclays Global Fund Advisors and other

entities in the Barclays Global Investors business

now lies with BlackRock.

14 Contact name:

Andrew Wood

15. Contact telephone name:

01865 783000